{
  "nct_id": "NCT18555929",
  "indication": "Prostate Cancer",
  "phase": "Phase 2",
  "sample_size": 135,
  "duration_weeks": 80,
  "dropout_rate": 0.27,
  "blinding": "open-label",
  "control_arm": "active comparator",
  "primary_endpoints": [
    "PSA response"
  ],
  "secondary_endpoints": [
    "Overall survival",
    "Time to PSA progression"
  ],
  "outcome_summary": "Primary endpoint met with statistical significance (p<0.05)",
  "success": 1,
  "start_date": "2019-08-27",
  "completion_date": "2021-03-09"
}